Applied Finance Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1M Buy
12,549
+11,605
+1,229% +$11.9M 1.12% 35
2026
Q1
$868K Sell
944
-181
-16% -$183K 0.07% 116
2025
Q4
$1.21M Sell
1,125
-28
-2% -$26.8K 0.09% 85
2025
Q3
$880K Buy
1,153
+100
+9% +$74.4K 0.06% 124
2025
Q2
$821K Sell
1,053
-1
-0.1% -$777 0.06% 147
2025
Q1
$871K Buy
1,054
+199
+23% +$166K 0.06% 130
2024
Q4
$660K Buy
855
+12
+1% +$9.94K 0.03% 157
2024
Q3
$747K Buy
843
+183
+28% +$165K 0.03% 160
2024
Q2
$598K Buy
660
+143
+28% +$114K 0.03% 167
2024
Q1
$402K Hold
517
0.03% 54
2023
Q4
$301K Sell
517
-189
-27% -$110K 0.03% 68
2023
Q3
$379K Sell
706
-86
-11% -$44.3K 0.04% 51
2023
Q2
$371K Buy
792
+35
+5% +$14.7K 0.04% 51
2023
Q1
$260K Buy
757
+82
+12% +$27.7K 0.03% 57
2022
Q4
$247K Buy
+675
New +$239K 0.03% 52

Other funds holding LLY

Applied Finance Capital Management's LLY Position: Q2 2026 in Review

Applied Finance Capital Management increased its Eli Lilly (LLY) stake by 1,229% in Q2 2026, buying an estimated $11.9M and bringing the position to 12,549 shares worth $15.1M. The position accounts for 1.12% of the portfolio, ranked #35.

Applied Finance Capital Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Applied Finance Capital Management held 12,549 shares of Eli Lilly worth $15.1M as of Q2 2026.
  • Applied Finance Capital Management bought 11,605 Eli Lilly shares in Q2 2026, an estimated $11.9M.
  • Eli Lilly made up 1.12% of Applied Finance Capital Management's portfolio in Q2 2026, its #35 holding.
  • Applied Finance Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.